Rowan Digital Works

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis., Toni‐Kim Clarke, Paul J. Bloch, Lisa M. Ambrose‐Lanci, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O'Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro

Further evidence for association between genetic variants in the cannabinoid receptor 1 (CNR1) gene and cocaine dependence: Confirmation in an independent sample and meta-analysis, Toni-Kim Clarke, Paul J. Bloch, Lisa M. Ambrose-Lanci, Glenn A. Doyle, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine., Toni-Kim Clarke, Richard C. Crist, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro

Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European American population, Lisa M. Ambrose-Lanci, Meera Vaswani, Toni Kim Clarke, Angela Zeng, Falk W. Lohoff, Thomas N. Ferraro, Wade H. Berrettini
Thomas Ferraro

Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Rachel Hodge, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Charles A. Dackis, Charles P. O'brien, Helen M. Pettinati, David W. Oslin
Thomas Ferraro

Pharmacogenetic considerations in the treatment of psychiatric disorders, Falk W. Lohoff, Thomas N. Ferraro
Thomas Ferraro

Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence., Falk W. Lohoff, Paul J. Bloch, Thomas N. Ferraro, Wade H. Berrettini, Helen M. Pettinati, Charles A. Dackis, Charles P. O’Brien, Kyle M. Kampman, David W. Oslin
Thomas Ferraro

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Russell Buono

Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro

Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence., Falk W. Lohoff, Andrew E. Weller, Paul J. Bloch, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, David W. Oslin, Charles A. Dackis, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro

Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence, John P. Dahl, Joseph F. Cubells, Riju Ray, Andrew E. Weller, Falk W. Lohoff, Thomas N. Ferraro, David W. Oslin, Kyle M. Kampman, Charles Dackis, Yilang Tang, Joel Gelernter, Henry R. Kranzler, Charles P. O'brien, Wade H. Berrettini
Thomas Ferraro

Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence., John P. Dahl, Glenn A. Doyle, David W. Oslin, Russell J. Buono, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro

Lack of association between single nucleotide polymorphisms in the corticotropin releasing hormone receptor 1 (CRHR1) gene and alcohol dependence., John P. Dahl, Glenn A. Doyle, David W. Oslin, Russell J. Buono, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Russell Buono